Late thrombosis in cypher stents after the discontinuation of antiplatelet therapy.
Drug-eluting stents, since their approval in the United States, have become the treatment of choice for de novo coronary artery narrowing due to their ability to reduce restenosis and the need for repeat revascularization. We present two patients who underwent percutaneous coronary intervention for the treatment of multivessel coronary artery disease; both patients were treated with sirolimus-eluting stents (SES) and bare metal stents (BMS).
Stabile
Eugenio
E
Division of Cardiology, Washington Hospital Center, DC 20010, USA.
Cheneau
Edouard
E
Kinnaird
Timothy
T
Suddath
William O
WO
Weissman
Neil J
NJ
Torguson
Rebecca
R
Kent
Kenneth M
KM
Pichard
Augusto D
AD
Satler
Lowell F
LF
Waksman
Ron
R
D000328:Adult; D015906:Angioplasty, Balloon, Coronary; D003324:Coronary Artery Disease / Q000628:therapy*; D003328:Coronary Thrombosis / Q000000981:diagnostic imaging / Q000209:etiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D011859:Radiography; D020123:Sirolimus / Q000008:administration & dosage; D015607:Stents; D016312:Treatment Refusal; D028761:Withholding Treatment
D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D020123:Sirolimus